Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study-Reference-Cited by-同舟云学术

Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study

Published:2018-09-03 Issue:5 Volume:19 Page:165-171
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Wynne Joshua¹,Muwawu Rosemary²,Mubiru Michael C²,Kamira Betty²,Kemigisha Doreen²,Nakyanzi Teopista²,Kabwigu Samuel²,Nakabiito Clemensia²,Kiweewa Matovu Flavia²³^ORCID

Affiliation:

1. Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA;

2. Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda;

3. Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda

Funder

Microbicide Trials Network

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1080/15284336.2018.1513711

Reference19 articles.

1. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

2. Barriers to Recruitment and Retention of HIV-Negative Black South African Women into Behavioral HIV Prevention Programs